Growth Metrics

GeneDx Holdings (WGS) Other Non-Current Liabilities (2020 - 2026)

GeneDx Holdings has reported Other Non-Current Liabilities over the past 7 years, most recently at $71000.0 for Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 98.93% to $71000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $71000.0 through Mar 2026, down 98.93% year-over-year, with the annual reading at $1.6 million for FY2025, 70.27% down from the prior year.
  • Other Non-Current Liabilities was $71000.0 for Q1 2026 at GeneDx Holdings, down from $1.6 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $24.0 million in Q4 2022 and troughed at $71000.0 in Q1 2026.
  • The 5-year median for Other Non-Current Liabilities is $6.6 million (2025), against an average of $9.8 million.
  • Year-over-year, Other Non-Current Liabilities surged 5654.55% in 2024 and then plummeted 98.93% in 2026.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $24.0 million in 2022, then plummeted by 38.65% to $14.7 million in 2023, then crashed by 62.54% to $5.5 million in 2024, then tumbled by 70.27% to $1.6 million in 2025, then crashed by 95.67% to $71000.0 in 2026.
  • Per Business Quant, the three most recent readings for WGS's Other Non-Current Liabilities are $71000.0 (Q1 2026), $1.6 million (Q4 2025), and $4.3 million (Q3 2025).